Handelsbanken Fonder AB reduced its position in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 5.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 115,681 shares of the technology company’s stock after selling 6,672 shares during the quarter. Handelsbanken Fonder AB’s holdings in Veeva Systems were worth $25,823,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also bought and sold shares of the company. Vanguard Group Inc. increased its position in Veeva Systems by 3.1% in the third quarter. Vanguard Group Inc. now owns 15,429,231 shares of the technology company’s stock worth $4,596,522,000 after buying an additional 457,806 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Veeva Systems by 4.1% in the third quarter. Alliancebernstein L.P. now owns 5,941,631 shares of the technology company’s stock worth $1,770,071,000 after acquiring an additional 235,983 shares during the period. Principal Financial Group Inc. boosted its holdings in shares of Veeva Systems by 0.6% in the fourth quarter. Principal Financial Group Inc. now owns 3,870,293 shares of the technology company’s stock worth $863,978,000 after acquiring an additional 23,416 shares during the period. State Street Corp boosted its holdings in shares of Veeva Systems by 2.2% in the third quarter. State Street Corp now owns 3,503,730 shares of the technology company’s stock worth $1,043,796,000 after acquiring an additional 76,397 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Veeva Systems by 4.8% in the third quarter. JPMorgan Chase & Co. now owns 3,476,258 shares of the technology company’s stock worth $1,035,622,000 after acquiring an additional 159,984 shares during the period. 88.20% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Veeva Systems
In other Veeva Systems news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction dated Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the sale, the director owned 3,253 shares of the company’s stock, valued at $506,296.92. The trade was a 18.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
View Our Latest Analysis on Veeva Systems
Veeva Systems Stock Performance
NYSE:VEEV opened at $165.10 on Thursday. The firm has a market capitalization of $26.96 billion, a price-to-earnings ratio of 30.52, a P/E/G ratio of 0.73 and a beta of 0.92. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50. The stock has a fifty day moving average of $169.55 and a 200 day moving average of $205.57.
Veeva Systems (NYSE:VEEV – Get Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $835.95 million during the quarter, compared to analyst estimates of $810.95 million. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The firm’s quarterly revenue was up 16.0% on a year-over-year basis. During the same quarter last year, the company earned $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. Equities analysts forecast that Veeva Systems Inc. will post 6.41 earnings per share for the current fiscal year.
Veeva Systems News Roundup
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Investor sentiment improved after Michael Burry was reported to hold a position in Veeva Systems, adding a high-profile endorsement for the stock. Veeva Systems Inc. (VEEV): Michael Burry Admires This Software Stock
- Positive Sentiment: Multiple articles highlighted Veeva’s RTSM momentum, major pharma wins, and durable long-term growth drivers in clinical software, reinforcing the bull case for the business. Veeva Systems’ RTSM Momentum Signals Another Long-Term Growth Driver
- Positive Sentiment: Coverage also framed Veeva as a strong growth stock with healthy fundamentals and long-term investor appeal, which can help support the shares. Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
- Neutral Sentiment: Another article repeated the argument that Veeva has strong long-term growth potential and is attracting institutional interest, but it was largely reiterative rather than a new catalyst. Long-Term Growth Potential Driving Investor Interest In Veeva Systems Inc. (VEEV)
- Neutral Sentiment: Analyst commentary remained generally optimistic overall, though one report noted Oppenheimer trimmed its price target to $225, which may limit enthusiasm somewhat. Veeva Systems (NYSE:VEEV) Price Target Lowered to $225.00 at Oppenheimer
- Negative Sentiment: One market recap said Veeva rose but still lagged the broader market, suggesting the move may reflect cautious trading rather than a decisive breakout. Veeva Systems (VEEV) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
